Lead-exposure associated miRNAs in humans and Alzheimer's disease as potential biomarkers of the disease and disease processes

Qingfeng Wen*, Marcha Verheijen, Mandy Melissa Jane Wittens, Julia Czuryło, Sebastiaan Engelborghs, Duncan Hauser, Marcel H M van Herwijnen, Thomas Lundh, Ingvar A Bergdahl, Soterios A Kyrtopoulos, Theo M de Kok, Hubert J M Smeets, Jacco Jan Briedé, Julian Krauskopf

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Alzheimer's disease (AD) is a neurodegenerative disease that eventually affects memory and behavior. The identification of biomarkers based on risk factors for AD provides insight into the disease since the exact cause of AD remains unknown. Several studies have proposed microRNAs (miRNAs) in blood as potential biomarkers for AD. Exposure to heavy metals is a potential risk factor for onset and development of AD. Blood cells of subjects that are exposed to lead detected in the circulatory system, potentially reflect molecular responses to this exposure that are similar to the response of neurons. In this study we analyzed blood cell-derived miRNAs derived from a general population as proxies of potentially AD-related mechanisms triggered by lead exposure. Subsequently, we analyzed these mechanisms in the brain tissue of AD subjects and controls. A total of four miRNAs were identified as lead exposure-associated with hsa-miR-3651, hsa-miR-150-5p and hsa-miR-664b-3p being negatively and hsa-miR-627 positively associated. In human brain derived from AD and AD control subjects all four miRNAs were detected. Moreover, two miRNAs (miR-3651, miR-664b-3p) showed significant differential expression in AD brains versus controls, in accordance with the change direction of lead exposure. The miRNAs' gene targets were validated for expression in the human brain and were found enriched in AD-relevant pathways such as axon guidance. Moreover, we identified several AD relevant transcription factors such as CREB1 associated with the identified miRNAs. These findings suggest that the identified miRNAs are involved in the development of AD and might be useful in the development of new, less invasive biomarkers for monitoring of novel therapies or of processes involved in AD development.

Original languageEnglish
Article number15966
Number of pages14
JournalScientific Reports
Volume12
Issue number1
DOIs
Publication statusPublished - 24 Sept 2022

Keywords

  • Alzheimer Disease/genetics
  • Biomarkers
  • Humans
  • Lead/toxicity
  • MicroRNAs/metabolism
  • Neurodegenerative Diseases
  • Transcription Factors

Cite this